Direkt zum Inhalt
Merck
Alle Fotos(2)

Key Documents

View All Documentation

GF84327037

Yttrium

rod, 50mm, diameter 12.5mm, cast, 99%

Synonym(e):

Yttrium

Anmeldenzur Ansicht organisationsspezifischer und vertraglich vereinbarter Preise
Alle Fotos(2)

About This Item

Empirische Formel (Hill-System):
Y
CAS-Nummer:
7440-65-5
Molekulargewicht:
88.91
MDL-Nummer:
MFCD00011468
UNSPSC-Code:
12141617
PubChem Substanz-ID:
329812679
NACRES:
NA.23

Assay

99%

Form

rod

Hersteller/Markenname

Goodfellow 843-270-37

Widerstandsfähigkeit

57 μΩ-cm, 20°C

L × Durchm.

50 mm × 12.5 mm

bp

3338 °C (lit.)

mp (Schmelzpunkt)

1522 °C (lit.)

Dichte

4.469 g/mL at 25 °C (lit.)

SMILES String

[Y]

InChI

1S/Y

InChIKey

VWQVUPCCIRVNHF-UHFFFAOYSA-N

Suchen Sie nach ähnlichen Produkten? Aufrufen Leitfaden zum Produktvergleich

Allgemeine Beschreibung

For updated SDS information please visit www.goodfellow.com.

Rechtliche Hinweise

Product of Goodfellow

Lagerklassenschlüssel

13 - Non Combustible Solids

WGK

WGK 3

Flammpunkt (°F)

Not applicable

Flammpunkt (°C)

Not applicable

Hier finden Sie alle aktuellen Versionen:

Analysenzertifikate (COA)

Lot/Batch Number

Leider sind derzeit keine COAs für dieses Produkt online verfügbar.

Wenn Sie Hilfe benötigen, wenden Sie sich bitte an Kundensupport

Besitzen Sie dieses Produkt bereits?

In der Dokumentenbibliothek finden Sie die Dokumentation zu den Produkten, die Sie kürzlich erworben haben.

Die Dokumentenbibliothek aufrufen

Yukiko Ishihara et al.
Analytical sciences : the international journal of the Japan Society for Analytical Chemistry, 31(8), 781-785 (2015-08-11)
With a view to enhance the sensitivity of analytical instruments used in the measurement of trace elements contained in a single cell, we have now equipped the previously reported micro-droplet injection system (M-DIS) with a desolvation system. This modified M-DIS
Hojjat Ahmadzadehfar et al.
Seminars in nuclear medicine, 40(2), 105-121 (2010-02-02)
Radioembolization (RE), also termed selective internal radiation therapy (SIRT), has been gradually introduced to the clinical arsenal of cytoreductive modalities in recent years. There is growing evidence for efficiency in liver tumors of various entities, with the most prominent ones
Dan Li et al.
Journal of nanoscience and nanotechnology, 14(6), 4207-4213 (2014-04-18)
YF3:Er3+ hollow nanofibers were successfully fabricated via fluorination of the relevant Y2O3:Er3+ hollow nanofibers which were obtained by calcining the electrospun PVP/[Y(NO3)3 + Er(NO3)3] composite nanofibers. The morphology and properties of the products were investigated in detail by X-ray diffraction
G Scholz et al.
Dalton transactions (Cambridge, England : 2003), 44(30), 13522-13529 (2015-07-03)
Nanoscopic yttrium acetate fluorides Y(CH(3)COO)(3-z)F(z) and yttrium oxide fluorides YO(3-z)/(2)F(z )were prepared with tunable Y/F molar ratios via the fluorolytic sol-gel route. All samples were characterized by X-ray diffraction, elemental analysis and thermal analysis. In addition, local structures of all
Ryan Hickey et al.
International journal of radiation oncology, biology, physics, 88(5), 1025-1031 (2014-03-26)
Radiosensitizing chemotherapy improves the outcomes in comparison with radiation alone for gastrointestinal cancers. The delivery of radiation therapy with yttrium90 ((90)Y) radioembolization, in combination with the radiosensitizing chemotherapeutic agent capecitabine, provides the opportunity to enhance the effects of radiation on
Alle zugehörigen Dokumente anzeigen

Unser Team von Wissenschaftlern verfügt über Erfahrung in allen Forschungsbereichen einschließlich Life Science, Materialwissenschaften, chemischer Synthese, Chromatographie, Analytik und vielen mehr..

Setzen Sie sich mit dem technischen Dienst in Verbindung.